JPMorgan Chase & Co. set a €34.90 ($40.58) price target on Siemens Healthineers (ETR:SHL) in a research note issued to investors on Thursday. The brokerage currently has a neutral rating on the stock.

Several other analysts have also recently commented on the stock. Sanford C. Bernstein set a €41.00 ($47.67) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a research note on Wednesday, January 2nd. HSBC set a €43.00 ($50.00) price objective on shares of Siemens Healthineers and gave the stock a buy rating in a research report on Monday, December 3rd. Berenberg Bank set a €43.00 ($50.00) price objective on shares of Siemens Healthineers and gave the stock a buy rating in a research report on Thursday, November 29th. Deutsche Bank set a €38.00 ($44.19) price objective on shares of Siemens Healthineers and gave the stock a neutral rating in a research report on Wednesday, November 14th. Finally, Independent Research set a €39.00 ($45.35) target price on shares of Siemens Healthineers and gave the stock a neutral rating in a research note on Tuesday, November 6th. Fourteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Siemens Healthineers presently has an average rating of Hold and an average target price of €38.39 ($44.64).

Siemens Healthineers stock traded down €0.45 ($0.52) during mid-day trading on Thursday, hitting €34.52 ($40.14). The stock had a trading volume of 730,874 shares.

Siemens Healthineers Company Profile

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Further Reading: Blue-Chip Stocks

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.